119 related articles for article (PubMed ID: 16165087)
1. Molecular dynamics studies of the full-length integrase-DNA complex.
De Luca L; Vistoli G; Pedretti A; Barreca ML; Chimirri A
Biochem Biophys Res Commun; 2005 Nov; 336(4):1010-6. PubMed ID: 16165087
[TBL] [Abstract][Full Text] [Related]
2. Constructing HIV-1 integrase tetramer and exploring influences of metal ions on forming integrase-DNA complex.
Wang LD; Liu CL; Chen WZ; Wang CX
Biochem Biophys Res Commun; 2005 Nov; 337(1):313-9. PubMed ID: 16188234
[TBL] [Abstract][Full Text] [Related]
3. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity.
Greenwald J; Le V; Butler SL; Bushman FD; Choe S
Biochemistry; 1999 Jul; 38(28):8892-8. PubMed ID: 10413462
[TBL] [Abstract][Full Text] [Related]
4. Structural dynamics of full-length retroviral integrase: a molecular dynamics analysis.
Balasubramanian S; Rajagopalan M; Ramaswamy A
J Biomol Struct Dyn; 2012; 29(6):659-70. PubMed ID: 22545997
[TBL] [Abstract][Full Text] [Related]
5. Prediction of HIV-1 integrase/viral DNA interactions in the catalytic domain by fast molecular docking.
Adesokan AA; Roberts VA; Lee KW; Lins RD; Briggs JM
J Med Chem; 2004 Feb; 47(4):821-8. PubMed ID: 14761184
[TBL] [Abstract][Full Text] [Related]
6. Hyrtiosal, from the marine sponge Hyrtios erectus, inhibits HIV-1 integrase binding to viral DNA by a new inhibitor binding site.
Du L; Shen L; Yu Z; Chen J; Guo Y; Tang Y; Shen X; Jiang H
ChemMedChem; 2008 Jan; 3(1):173-80. PubMed ID: 17943714
[TBL] [Abstract][Full Text] [Related]
7. Study on the molecular mechanism of inhibiting HIV-1 integrase by EBR28 peptide via molecular modeling approach.
Hu JP; Gong XQ; Su JG; Chen WZ; Wang CX
Biophys Chem; 2008 Feb; 132(2-3):69-80. PubMed ID: 18037557
[TBL] [Abstract][Full Text] [Related]
8. Comparative molecular dynamics simulations of HIV-1 integrase and the T66I/M154I mutant: binding modes and drug resistance to a diketo acid inhibitor.
Brigo A; Lee KW; Fogolari F; Mustata GI; Briggs JM
Proteins; 2005 Jun; 59(4):723-41. PubMed ID: 15815973
[TBL] [Abstract][Full Text] [Related]
9. Docking dinucleotides to HIV-1 integrase carboxyl-terminal domain to find possible DNA binding sites.
Zhu HM; Chen WZ; Wang CX
Bioorg Med Chem Lett; 2005 Jan; 15(2):475-7. PubMed ID: 15603976
[TBL] [Abstract][Full Text] [Related]
10. Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
[TBL] [Abstract][Full Text] [Related]
11. Communications: Electron polarization critically stabilizes the Mg2+ complex in the catalytic core domain of HIV-1 integrase.
Lu Y; Mei Y; Zhang JZ; Zhang D
J Chem Phys; 2010 Apr; 132(13):131101. PubMed ID: 20387913
[TBL] [Abstract][Full Text] [Related]
12. Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.
Chen X; Tsiang M; Yu F; Hung M; Jones GS; Zeynalzadegan A; Qi X; Jin H; Kim CU; Swaminathan S; Chen JM
J Mol Biol; 2008 Jul; 380(3):504-19. PubMed ID: 18565342
[TBL] [Abstract][Full Text] [Related]
13. Complexes of HIV-1 integrase with HAT proteins: multiscale models, dynamics, and hypotheses on allosteric sites of inhibition.
Di Fenza A; Rocchia W; Tozzini V
Proteins; 2009 Sep; 76(4):946-58. PubMed ID: 19306343
[TBL] [Abstract][Full Text] [Related]
14. Brownian and essential dynamics studies of the HIV-1 integrase catalytic domain.
Weber W; Demirdjian H; Lins RD; Briggs JM; Ferreira R; McCammon JA
J Biomol Struct Dyn; 1998 Dec; 16(3):733-45. PubMed ID: 10052629
[TBL] [Abstract][Full Text] [Related]
15. Similarities in the HIV-1 and ASV integrase active sites upon metal cofactor binding.
Lins RD; Straatsma TP; Briggs JM
Biopolymers; 2000 Apr; 53(4):308-15. PubMed ID: 10685051
[TBL] [Abstract][Full Text] [Related]
16. Modeling HIV-1 integrase complexes based on their hydrodynamic properties.
Podtelezhnikov AA; Gao K; Bushman FD; McCammon JA
Biopolymers; 2003 Jan; 68(1):110-20. PubMed ID: 12579583
[TBL] [Abstract][Full Text] [Related]
17. Structural and dynamical properties of a full-length HIV-1 integrase: molecular dynamics simulations.
Wijitkosoom A; Tonmunphean S; Truong TN; Hannongbua S
J Biomol Struct Dyn; 2006 Jun; 23(6):613-24. PubMed ID: 16615807
[TBL] [Abstract][Full Text] [Related]
18. Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.
Li HY; Zawahir Z; Song LD; Long YQ; Neamati N
J Med Chem; 2006 Jul; 49(15):4477-86. PubMed ID: 16854053
[TBL] [Abstract][Full Text] [Related]
19. Understanding the effect of drug-resistant mutations of HIV-1 intasome on raltegravir action through molecular modeling study.
Xue W; Qi J; Yang Y; Jin X; Liu H; Yao X
Mol Biosyst; 2012 Aug; 8(8):2135-44. PubMed ID: 22648037
[TBL] [Abstract][Full Text] [Related]
20. Effects of varying the spacing within the D,D-35-E motif in the catalytic region of retroviral integrase.
Konsavage WM; Sudol M; Katzman M
Virology; 2008 Sep; 379(2):223-33. PubMed ID: 18687451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
